Myocardial protection by interferon-γ late preconditioning during cardiopulmonary bypass-associated myocardial ischemia-reperfusion in pigs

Oncology Reports

Volumn 30, Issue 5, 2013, Pages 2145-2152

  Yan, Xiangang ^a   Qiu, Wanshan ^a   Jia, Bing ^a   Zhong, Hui ^a   Li, Xin ^b   Chen, Zhanggen ^a  

^a CHILDREN S HOSPITAL OF FUDAN UNIVERSITY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cardiopulmonary bypass; Interferon ; Late preconditioning; Myocardial ischemia reperfusion injury

Indexed keywords

CREATINE KINASE MB; GAMMA INTERFERON; HEAT SHOCK PROTEIN 70; INDUCIBLE NITRIC OXIDE SYNTHASE; MANGANESE SUPEROXIDE DISMUTASE; SODIUM CHLORIDE; TROPONIN I;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; DRUG MECHANISM; GENDER; HEART HEMODYNAMICS; HEART INFARCTION PREVENTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE ENDSYSTOLIC PRESSURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART RATE; IN VIVO STUDY; NONHUMAN; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY; SWINE;

ANIMALS; CARDIOPULMONARY BYPASS; CORONARY ARTERY DISEASE; FEMALE; HSP72 HEAT-SHOCK PROTEINS; HUMANS; INTERFERON-GAMMA; MALE; MYOCARDIAL REPERFUSION INJURY; NITRIC OXIDE SYNTHASE TYPE II; SUPEROXIDE DISMUTASE; SWINE;

EID: 84885029272     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2707     Document Type: Article

References (41)

1. Pinto DS, Gibson CM and Wykrzykowska JJ: Ischemic reperfusion injury of the heart. (Literature Review). Wolters-Kluwer Health, 2012.
2. Nolan SP, Zacour R and Dammann JF: Reflections on the evolution of cardiopulmonary bypass. Ann Thorac Surg 64: 1540-1543, 1997.
3. Murphy GJ and Angelini GD: Side effects of cardiopulmonary bypass: what is the reality? J Card Surg 19: 481-488, 2004.
4. Sheehan FH, Doerr R, Schmidt WG, et al: Early recovery of left ventricular function after thrombolytic therapy for acute myocardial infarction: an important determinant of survival. J Am Coll Cardiol 12: 289-300, 1988.
5. Egan JR, Butler TL, Cole AD, et al: Myocardial ischemia is more important than the effects of cardiopulmonary bypass on myocardial water handling and postoperative dysfunction: a pediatric animal model. J Thorac Cardiovasc Surg 136: 1265-1273, 2008.
6. Kovacević M, Simić O, Jonjić N and Stifter S: Apoptosis and cardiopulmonary bypass. J Card Surg 22: 129-134, 2007.
7. Perrault LP and Menasché P: Preconditioning: can nature's shield be raised against surgical ischemic-reperfusion injury? Ann Thorac Surg 68: 1988-1994, 1999.
8. Murry CE, Jennings RB and Reimer KA: Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74: 1124-1136, 1986.
9. Goto M, Liu Y, Yang XM, Ardell JL, Cohen MV and Downey JM: Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res 77: 611-621, 1995.
10. Przyklenk K, Kloner RA and Yellon DM (eds): Ischemic Preconditioning: The Concept of Endogenous Cardioprotection. Kluwer Academic Publishers, Boston, 1994.
11. Lee HT: Mechanisms of ischemic preconditioning and clinical implications for multiorgan ischemic-reperfusion injury. J Cardiothorac Vasc Anesth 13: 78-91, 1999.
12. Valen G: The basic biology of apoptosis and its implications for cardiac function and viability. Ann Thorac Surg 75: S656-S660, 2003.
13. Kajstura J, Cigola E, Malhotra A, et al: Angiotensin II induces apoptosis of adult ventricular myocytes in vitro. J Mol Cell Cardiol 29: 859-870, 1997.
14. Geng YJ, Wu Q, Muszynski M, Hansson GK and Libby P: Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-γ, tumor necrosis factor-α, and interleukin-1β. Arterioscler Thromb Vasc Biol 16: 19-27, 1996.
15. Joyeux M, Godin-Ribuot D, Yellon DM, Demenge P and Ribuot C: Heat stress response and myocardial protection. Fundam Clin Pharmacol 13: 1-10, 1999.
16. Das DK, Maulik N and Moraru II: Gene expression in acute myocardial stress. Induction by hypoxia, ischemia, reperfusion, hyperthermia and oxidative stress. J Mol Cell Cardiol 27: 181-193, 1995.
17. Csont T, Viappiani S, Sawicka J, et al: The involvement of superoxide and iNOS-derived NO in cardiac dysfunction induced by pro-inflammatory cytokines. J Mol Cell Cardiol 39: 833-840, 2005.
18. Knaapen MW, Davies MJ, De Bie M, Haven AJ, Martinet W and Kockx MM: Apoptotic versus autophagic cell death in heart failure. Cardiovasc Res 51: 304-312, 2001.
19. Jynge P, Hearse DJ, Feuvray D, et al: The St. Thomas' hospital cardioplegic solution: a characterization in two species. Scand J Thorac Cardiovasc Surg (Suppl 30): 1-28, 1981.
20. Brinkman AC, Romijn JW, van Barneveld LJ, et al: Profound effects of cardiopulmonary bypass priming solutions on the fibrin part of clot formation: an ex vivo evaluation using rotation thromboelastometry. J Cardiothorac Vasc Anesth 24: 422-426, 2010.
21. Gullu AU, Senay S, Kocyigit M and Alhan C: A simple method for occlusion of both venae cavae in total cardiopulmonary bypass for robotic surgery. Interact Cardiovasc Thorac Surg 14: 138-139, 2012.
22. Weisel RD, Mickle DA, Finkle CD, Tumiati LC, Madonik MM and Ivanov J: Delayed myocardial metabolic recovery after blood cardioplegia. Ann Thorac Surg 48: 503-507, 1989.
23. Takahashi T: Toll-like receptors and myocardial contractile dysfunction. Cardiovasc Res 78: 3-4, 2008.
24. Onorati F, Renzulli A, De Feo M, et al: Perioperative enoximone infusion improves cardiac enzyme release after CABG. J Cardiothorac Vasc Anesth 18: 409-414, 2004.
25. Boldt J, Rothe G, Schindler E, Doll C, Görlach G and Hempelmann G: Can clonidine, enoximone, and enalaprilat help to protect the myocardium against ischaemia in cardiac surgery? Heart 76: 207-213, 1996.
26. Pexieder T: Cell death in the morphogenesis and teratogenesis of the heart. Adv Anat Embryol Cell Biol 51: 3-99, 1975.
27. James TN: Normal and abnormal consequences of apoptosis in the human heart. From postnatal morphogenesis to paroxysmal arrhythmias. Circulation 90: 556-573, 1994.
28. Dominov JA, Houlihan-Kawamoto CA, Swap CJ and Miller JB: Pro- and anti-apoptotic members of the Bcl-2 family in skeletal muscle: a distinct role for Bcl-2 in later stages of myogenesis. Dev Dyn 220: 18-26, 2001.
29. Yavuz S, Kasap M, Parlar H, et al: Heat shock proteins and myocardial protection during cardiopulmonary bypass. J Int Med Res 39: 499-507, 2011.
30. Anselmi A, Abbate A, Girola F, et al: Myocardial ischemia, stunning, inflammation, and apoptosis during cardiac surgery: a review of evidence. Eur J Cardiothorac Surg 25: 304-311, 2004.
31. Wang L, Li W, Kang Z, et al: Hyperbaric oxygen preconditioning attenuates early apoptosis after spinal cord ischemia in rats. J Neurotrauma 26: 55-66, 2009.
32. Sellke FW: Vascular changes after cardiopulmonary bypass and ischemic cardiac arrest: roles of nitric oxide synthase and cyclooxygenase. Braz J Med Biol Res 32: 1345-1352, 1999.
33. Toprak V, Sirin BH, Tok D, Ozbilgin K and Saribülbül O: The effect of cardiopulmonary bypass on the expression of inducible nitric oxide synthase, endothelial nitric oxide synthase, and vascular endothelial growth factor in the internal mammary artery. J Cardiothorac Vasc Anesth 20: 63-67, 2006.
34. Papapetropoulos A, Andreopoulos S, Go CY, Hoque A, Fuchs LC and Catravas JD: Regulation of the nitric oxide synthase-nitric oxide-cGMP pathway in rat mesenteric endothelial cells. J Appl Physiol 91: 2553-2560, 2001.
35. Bolli R: Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research. J Mol Cell Cardiol 33: 1897-1918, 2001.
36. Stone JR and Marletta MA: Spectral and kinetic studies on the activation of soluble guanylate cyclase by nitric oxide. Biochemistry 35: 1093-1099, 1996.
37. Nong Z, Hoylaerts M, Van Pelt N, Collen D and Janssens S: Nitric oxide inhalation inhibits platelet aggregation and platelet-mediated pulmonary thrombosis in rats. Circ Res 81: 865-869, 1997.
38. del Río LA, Corpas FJ, Sandalio LM, Palma JM, Gómez M and Barroso JB: Reactive oxygen species, antioxidant systems and nitric oxide in peroxisomes. J Exp Bot 53: 1255-1272, 2002.
39. Yoon T, Cheon MS, Lee AY, et al: Anti-inflammatory activity of methylene chloride fraction from Glehnia littoralis extract via suppression of NF-κB and mitogen-activated protein kinase activity. J Pharmacol Sci 112: 46-55, 2010.
40. Rickover O, Zinman T, Kaplan D and Shainberg A: Exogenous nitric oxide triggers classic ischemic preconditioning by preventing intracellular Ca2+ overload in cardiomyocytes. Cell Calcium 43: 324-333, 2008.
41. Sareila O, Korhonen R, Kärpänniemi O, Nieminen R, Kankaanranta H and Moilanen E: JAK inhibitors AG-490 and WHI-P154 decrease IFN-γ-induced iNOS expression and NO production in macrophages. Mediators Inflamm 2006: 16161, 2006.